DailyDoctor Archive Specialties Get app
Back to the 29 September 2026 edition

Research · 02 of 05

Higher protein intake with training raised creatinine and cystatin C and lowered eGFR

When eGFR falls in someone who has raised their protein intake, ask about diet and recheck before diagnosing CKD.

Design
Randomised 2x3 factorial trial, secondary complete-case analysis
Population
83 of 108 women aged 40-77 doing resistance or concurrent training
Primary outcome
Lipid, kidney and liver biomarkers at 12 weeks by protein intake
Effect
Creatinine and cystatin C rose, eGFR fell, mainly 0.8 vs 1.6 or 2.2 g/kg/day

This randomised factorial trial assigned 108 women aged 40 to 77 to resistance training alone or with cycling, and to protein intakes of 0.8, 1.6 or 2.2 g/kg/day for 12 weeks. This secondary analysis of 83 completers examined blood lipids, kidney markers and liver enzymes.

Urea, blood urea nitrogen, creatinine and cystatin C rose and three eGFR estimates fell, with differences mainly between 0.8 g/kg and the two higher intakes and little between 1.6 and 2.2 g/kg. Lipids improved in all groups.

The authors state plainly that the changes in eGFR do not establish kidney injury or long-term harm, and that energy and food composition were not fully matched. The practical point is interpretive: a falling eGFR in someone who has sharply raised protein intake may reflect diet as much as kidney function.

  • Ask about recent changes in protein intake and supplements when interpreting a new fall in eGFR.
  • Remember that cystatin C also moved here, so switching markers may not remove the effect.
  • Recheck kidney function after a period of usual intake before labelling CKD on one result.
  • Advise patients with established CKD to discuss high-protein diets with their clinician or dietitian.

Why it matters

High-protein diets and supplements are common, and their effect on routine kidney markers can mislead.

Don't overread it

The changes in eGFR do not show kidney injury or long-term harm.

The statistics, in plain English

This was a secondary analysis of completers, which can introduce bias, and the trial was not designed to test kidney safety. The changes were in laboratory estimates over 12 weeks, not clinical outcomes.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

ckdtransplant

Tomorrow morning, before your first patient

One edition a day for nephrology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app